2013 OncPrac Summit: Corey Langer on managing NSCLC

feeds has 409 videos Subscribe Here

Description: Which lung cancer patients are eligible for bevacizumab therapy? What about maintenance therapy in this population? What's the latest on erlotinib therapy for EGFR-mutated patients? Find the answers to these questions as Dr. David Henry, Editor in Chief of COMMUNITY ONCOLOGY, speaks to Dr. Corey Langer about his presentation on molecular and histologic distinctions in the management of non-small-cell lung cancer.
OncChat from the 2013 Oncology Practice Summit, a conference hosted by COMMUNITY ONCOLOGY, THE JOURNAL OF SUPPORTIVE ONCOLOGY, and THE ONCOLOGY REPORT, March 21-23, 2013 in Las Vegas.
Shared By : feeds
Posted on : 04/22/13
Added : 6 years ago
Category : General